Why Can’t I Think Clearly in Perimenopause?
What we know about hormones, sleep, mood, and why “brain fog” is real—but not always what it seems.

Photo by Daria Trofimova on Unsplash
- 01“Brain fog” is not a diagnosis. It describes real experiences—forgetfulness, word-finding trouble, poor concentration, and mental fatigue—that can have many causes.
- 02Perimenopausal women are more likely to report cognitive symptoms than premenopausal women; some studies also detect modest objective changes, but brief screening tests can miss real-world cognitive strain.
- 03Hormonal fluctuation may contribute, but sleep disruption, hot flashes, anxiety, depression, ADHD, medications, alcohol, thyroid disease, nutritional deficiencies, and sleep apnea commonly overlap.
- 04Menopausal hormone therapy is not a reliable cognitive enhancer and should not be used solely to prevent dementia; treating sleep and vasomotor symptoms may indirectly help thinking.
- 05Subjective brain fog is usually not progressive dementia, but cognitive changes that are rapidly worsening or interfering with independent functioning deserve medical evaluation.
You walk into a room and forget why you went there.
A familiar name disappears in the middle of a conversation.
You reread the same email three times.
You start a task, get distracted, and suddenly cannot remember what you were doing.
Or maybe the problem is harder to describe.
You are still functioning. You are still working, parenting, managing appointments, making decisions, and doing the things you normally do.
But your brain just feels…slower.
For many women, this is one of the most unsettling symptoms of perimenopause.
And underneath the frustration is often a much scarier question:
Is this really perimenopause—or is something wrong with my brain?
Cognitive complaints are common during the menopause transition. Newer research also suggests that measurable cognitive changes can occur in some women.
But there is an important distinction:
Feeling cognitively different does not automatically mean your brain is deteriorating.
“Brain fog” is not a diagnosis. Hormonal changes may contribute, but sleep, hot flashes, anxiety, depression, ADHD, medications, alcohol, thyroid disease, nutritional deficiencies, sleep apnea, and many other factors can produce similar symptoms.
And while menopause-related cognitive changes are generally mild and quite different from progressive dementia, significant or worsening cognitive changes deserve evaluation.
What Does “Brain Fog” Actually Mean?
Brain fog is not a formal medical diagnosis.
It is a term used to describe experiences such as:
- forgetfulness
- difficulty concentrating
- losing your train of thought
- trouble finding words
- feeling mentally slower
- becoming more distractible
- trouble multitasking
- difficulty learning or retaining new information
- needing more reminders or lists
- walking into a room and forgetting why
- feeling less mentally sharp at work
For many women, the problem is not that they suddenly cannot think.
It is that thinking seems to require more effort than it used to.
That distinction helps explain why cognitive symptoms can be very disruptive even when a brief cognitive screening test looks normal.
Does Perimenopause Really Affect Cognition?
The evidence increasingly suggests that it can.
A 2026 systematic review and meta-analysis examined 26 studies involving 9,428 participants and found poorer overall cognitive performance in perimenopausal compared with premenopausal women.
However, there was an important methodological finding: the association was clearest when studies used standardized STRAW+10 criteria to define reproductive stage. Results were less consistent when menopause status was defined less rigorously.
That means perimenopause appears capable of affecting cognition, but historically researchers have not always been studying the same populations when they use the term “perimenopause.”
But a Large 2026 Study Found Very Little Difference on Cognitive Testing
This is where the story becomes more interesting.
A large 2026 community study evaluated 14,234 women ages 45 to 55 and compared self-reported cognitive symptoms with performance across eight computerized cognitive tasks.
Perimenopausal women had 31% higher odds of reporting cognitive symptoms than premenopausal women.
Yet objective cognitive performance differed very little among premenopausal, perimenopausal, and postmenopausal participants.
In fact, perimenopausal participants performed marginally better on global accuracy in some comparisons.
Most importantly, self-reported cognitive symptoms correlated only weakly with objective cognitive performance but were more strongly related to psychological symptoms.
That does not mean brain fog is imaginary.
It means something much more clinically useful:
How your brain functions under controlled testing conditions may not completely capture how difficult thinking feels in everyday life.
“My Testing Was Normal, But I Know I’m Different.”
Both can be true.
Imagine taking a cognitive test:
You are sitting quietly. Someone gives you one task at a time. There are no children asking questions, no incoming emails, no phone notifications, no dinner cooking, no meeting starting in five minutes, no night sweats keeping you awake, and no need to remember six unrelated things simultaneously.
Now compare that with an ordinary Tuesday.
Real-world cognition requires constant:
- task switching
- prioritization
- working memory
- sustained attention
- interruption management
- emotional regulation
Formal testing may therefore miss some of the cognitive strain women notice in daily life.
That is one reason subjective symptoms should not simply be dismissed because a screening test is normal.
Which Cognitive Functions May Change?
Studies have examined several domains, including:
- verbal learning
- verbal memory
- working memory
- attention
- processing speed
- executive function
- language
Women commonly report:
- “I can’t find words.”
- “I lose my train of thought.”
- “I can’t multitask anymore.”
- “I forget what someone just told me.”
- “I need to write everything down.”
Research has identified changes in verbal learning and memory, working memory, and processing speed in some women during the menopause transition.
But there is no single universal cognitive pattern.
Some women notice almost nothing. Others experience substantial symptoms.
Why Could Hormones Affect the Brain?
Estrogen acts well beyond the reproductive system.
Estrogen receptors are distributed throughout brain regions involved in:
- memory
- learning
- attention
- mood
- executive function
Estrogen also participates in processes involving:
- neurotransmitter signaling
- synaptic function
- cerebral blood flow
- glucose metabolism
- neuroplasticity
During perimenopause, estrogen levels do not simply decline steadily. They fluctuate.
That changing hormonal environment may influence how the brain functions in susceptible women.
But estrogen is almost certainly not the whole explanation.
Sleep May Be One of the Biggest Contributors to Brain Fog
Before assuming every forgotten word is directly caused by estrogen, ask:
How are you sleeping?
Perimenopause can disrupt sleep through:
- hot flashes
- night sweats
- insomnia
- anxiety
- frequent awakening
- restless sleep
And sleep deprivation affects exactly the functions women commonly describe as “brain fog”:
- concentration
- working memory
- attention
- processing speed
- recall
- emotional regulation
This can create a very predictable chain:
hot flashes → disrupted sleep → fatigue → poor concentration → brain fog
That distinction matters clinically.
If treating vasomotor symptoms allows someone to sleep through the night again, her concentration may improve even though estrogen was never acting as a direct “memory drug.”
Mood and Anxiety Matter Too
Anxiety can consume cognitive bandwidth.
When part of your attention is constantly monitoring worries, physical symptoms, work demands, children, aging parents, deadlines, and health concerns, less working memory is available for everything else.
Depression can similarly affect:
- attention
- processing speed
- motivation
- memory
- executive function
This does not mean women’s cognitive complaints should be dismissed as anxiety.
It means cognition, sleep, stress, and mood often interact during perimenopause and should be assessed together.
What About ADHD?
This is an increasingly common question.
Some women with established ADHD report that their symptoms become more difficult to manage around perimenopause.
Others begin recognizing lifelong patterns of distractibility, procrastination, executive dysfunction, and disorganization for the first time during midlife.
But the evidence here is still thin.
There is substantially less high-quality research specifically examining ADHD across the menopause transition than there is for general cognitive complaints.
So it would be premature to say: “Falling estrogen causes ADHD.”
A more reasonable interpretation is that perimenopause may occur alongside sleep disruption, mood symptoms, changing hormonal exposure, and increased life demands—factors that can make attention and executive-function difficulties much harder to compensate for.
If concentration problems have been present since childhood or early adulthood rather than newly developing in midlife, that history matters.
Can Progesterone Make You Feel Foggy?
Sometimes.
Progesterone is metabolized into neuroactive compounds including allopregnanolone, which interacts with GABA-A receptors in the brain.
That helps explain why oral micronized progesterone can have sedating effects.
For some women, bedtime progesterone helps with sleep.
For others, the next morning may involve sleepiness, sluggish thinking, fatigue, or grogginess.
If brain fog suddenly appears or worsens after beginning or changing progesterone—or any medication—the timing deserves attention.
That does not automatically mean the medication must be stopped. It means the regimen may need to be reviewed.
Does Hormone Therapy Improve Brain Fog?
This question deserves more nuance than either side of the debate usually receives.
The evidence does not show that menopausal hormone therapy is a reliable cognitive enhancer.
But it is also inaccurate to say that research shows absolutely no cognitive effects.
A 2024 systematic review and meta-analysis evaluated 34 randomized controlled trials, including 14,914 women receiving menopausal hormone therapy and 12,679 receiving placebo.
Across cognitive domains overall, MHT did not produce a consistent cognitive benefit.
However, several subgroup findings were interesting.
Among women receiving treatment for surgical menopause—mostly estrogen-only therapy—global cognition was better than with placebo.
And when estrogen therapy was started specifically in midlife or near menopause onset, researchers found a small improvement in verbal memory.
Estrogen started later in life did not show the same benefit.
That suggests timing and formulation may matter.
But subgroup findings are not the same as evidence that estrogen should be prescribed to improve memory.
Another meta-analysis of randomized trials found no significant improvement in several verbal-memory outcomes from MHT, including among recently menopausal women.
So the practical conclusion remains:
Hormone therapy should not be promised as a treatment for brain fog.
But cognitive effects may differ depending on the woman, timing, formulation, and underlying indication for treatment.
Treating Other Menopause Symptoms May Still Help Your Thinking
This is different from prescribing estrogen as a memory medication.
Imagine a woman who is waking six times every night because of hot flashes. She is exhausted, cannot concentrate, forgets things at work, and feels mentally slow.
If appropriate menopause treatment substantially reduces her hot flashes and restores sleep, she may feel dramatically clearer during the day.
That improvement does not prove estrogen directly restored her memory.
It may mean we successfully treated one of the major contributors to impaired daytime cognition.
That distinction matters.
What Do Brain Imaging Studies Show About Hormone Therapy?
Another rapidly developing area involves MRI research.
A 2026 systematic review identified 24 structural MRI studies evaluating menopausal hormone therapy and brain structure.
The findings were remarkably inconsistent.
Some studies suggested potentially protective structural associations. Others suggested structural decline.
The researchers concluded that factors such as timing of treatment, route of administration, formulation, duration, and participant characteristics may help explain the conflicting results.
This is fascinating research.
But MRI findings are not currently a reason to prescribe or avoid hormone therapy for an individual woman with ordinary brain fog.
Clinical decisions still need to be based on established indications, symptoms, risks, and preferences.
Should Hormone Therapy Be Used to Prevent Dementia?
No.
This is one of the areas where current guidance is clear.
NICE states: Do not offer combined or estrogen-only HRT for the purpose of dementia prevention.
This is important because discussions about estrogen and brain biology can easily morph into: “If I don’t take estrogen, I’ll get Alzheimer’s.”
The evidence does not support that conclusion.
Why Does Age at Starting HRT Matter?
Much of the concern about dementia and hormone therapy comes from the Women’s Health Initiative Memory Study—or WHIMS.
WHIMS enrolled women age 65 and older, which is very different from a typical 48- or 52-year-old considering hormone therapy for bothersome menopause symptoms.
In the combined estrogen-plus-progestin trial, women receiving conjugated equine estrogen plus medroxyprogesterone acetate had approximately twice the rate of probable dementia compared with placebo: 45 versus 22 cases per 10,000 person-years.
The estrogen-alone arm did not demonstrate the same statistically significant increase individually, although when WHIMS hormone-therapy trials were pooled, overall dementia risk was increased among these older initiators.
This is why it is misleading to take results from women who started therapy after age 65 and assume they automatically apply to women beginning treatment around the normal age of menopause.
NICE’s current guidance reflects this uncertainty.
For combined HRT, NICE states that dementia risk might increase when treatment is started at age 65 or older.
For estrogen-only HRT, NICE states that dementia risk is unlikely to increase.
NICE also explicitly notes that WHIMS participants were different from the typical population starting HRT because they initiated treatment at age 65 or older.
Estrogen-Only and Combined HRT May Not Have Identical Dementia Associations
Formulation appears important.
A large 2021 UK nested case-control study using QResearch and CPRD data found no overall increase in dementia risk associated with menopausal hormone therapy.
However, longer-term estrogen-plus-progestogen therapy was associated with a small increase in diagnosed Alzheimer’s disease:
- 5–9 years of use: adjusted OR 1.11
- 10 years or longer: adjusted OR 1.19
That translated to approximately five and seven additional Alzheimer’s cases per 10,000 woman-years, respectively.
Long-term estrogen-only therapy did not show the same increased Alzheimer’s signal; in some analyses it was associated with lower risk.
This was observational research, so it cannot prove that the hormone formulations caused those differences.
But it reinforces an important point:
“HRT” is not one single medication.
Risk may vary by:
- estrogen type
- whether a progestogen is required
- progestogen type
- route
- age at initiation
- duration of treatment
- underlying health
That is one reason broad claims that hormone therapy either “prevents Alzheimer’s” or “causes dementia” are both too simplistic.
Is Perimenopause Brain Fog the Same as Dementia?
Usually, no.
Typical menopause-related cognitive complaints may include:
- occasionally losing a word
- forgetting why you entered a room
- becoming more distractible
- needing additional reminders
- finding multitasking harder
- feeling mentally slower when exhausted
- losing your train of thought
These experiences can be frustrating and sometimes very disruptive.
But dementia involves something different: progressive cognitive decline that increasingly interferes with independent functioning.
The distinction is not: “Do you ever forget things?” Everyone does.
The more useful questions are:
- Is it progressively getting worse?
- Is it affecting your ability to manage everyday life?
What Cognitive Changes Are More Concerning?
Examples that deserve closer assessment include:
- repeatedly forgetting important recent events or conversations
- getting lost in familiar places
- difficulty managing finances that you previously handled easily
- repeatedly missing medication doses despite established routines
- significant difficulty performing familiar tasks
- major changes in judgment
- increasing difficulty following or participating in conversations
- marked personality or behavioral changes
- family members consistently noticing progressive decline
Brain fog associated with a terrible night of sleep is very different from progressively losing the ability to function independently.
Sudden Confusion Is Different
Perimenopause brain fog generally does not present as sudden severe confusion.
Acute onset of confusion, difficulty speaking, facial drooping, weakness or numbness, severe new headache, vision changes, or loss of coordination requires urgent medical evaluation.
Do not attribute sudden neurologic symptoms to menopause.
What Else Can Cause Brain Fog?
This is one of the most important parts of the evaluation.
A woman can be perimenopausal and have another cause of cognitive symptoms.
Depending on the history, possibilities include:
- sleep deprivation
- sleep apnea
- thyroid disease
- anemia
- iron deficiency
- vitamin B12 deficiency
- depression
- anxiety
- ADHD
- medication side effects
- alcohol use
- chronic pain
- migraine
- post-viral illness
- neurologic conditions
- other medical illnesses
There is no single universal “brain fog lab panel.”
Testing should be based on the actual history, symptoms, physical findings, medications, and risk factors.
Medication Review Matters
Some medications can contribute to:
- sedation
- impaired attention
- slowed processing
- memory problems
- confusion
Examples may include certain sleep medications, sedating antihistamines, muscle relaxants, bladder medications, anticholinergic drugs, some psychiatric medications, and pain medications.
Hormone regimens can also affect some women differently.
If cognitive symptoms began shortly after starting or adjusting a medication, the timeline is valuable information.
Do not stop prescription medication without discussing it with your healthcare professional.
What Actually Helps Perimenopause Brain Fog?
There is no medication specifically approved to treat “menopause brain fog.”
The most useful approach is identifying and treating the contributors that apply to you.
1. Start With Sleep
If you are sleeping four or five fragmented hours every night, sleep deserves attention before assuming you have a primary memory disorder.
Ask whether sleep is being disrupted by:
- hot flashes
- night sweats
- insomnia
- anxiety
- snoring
- possible sleep apnea
- restless legs
- medications
- alcohol
Improving sleep can make a substantial difference in daytime concentration.
2. Treat Bothersome Menopause Symptoms Appropriately
If vasomotor symptoms are repeatedly waking you, treating them may indirectly improve sleep, fatigue, concentration, productivity, and daytime functioning.
Hormone therapy is one treatment option for appropriate patients with bothersome vasomotor symptoms. Nonhormonal options also exist.
The goal is not to prescribe estrogen as a cognitive enhancer. It is to treat the symptoms that may be contributing to cognitive difficulty.
3. Exercise
Physical activity supports:
- cardiovascular health
- insulin sensitivity
- sleep
- mood
- physical function
- brain health
Regular aerobic activity and resistance training are both important during midlife.
And because cardiovascular and cerebrovascular health are closely connected, addressing physical activity is one of the more evidence-based long-term strategies for protecting cognition.
4. Protect Your Cardiovascular Health
Many of the strongest modifiable dementia risk factors have nothing to do with buying a “brain supplement.”
Pay attention to:
- blood pressure
- cholesterol
- diabetes
- smoking
- physical inactivity
- obesity
- excessive alcohol intake
What protects the cardiovascular system often helps protect the brain.
5. Stop Expecting Your Brain to Store Everything
External memory tools are useful—not a sign of failure.
Use:
- calendars
- reminders
- notes
- task lists
- alarms
- automatic bill payment
- medication organizers
- one consistent location for important items
Modern life places enormous demands on working memory.
You do not need to prove your brain is functioning by refusing to use systems that make your life easier.
6. Reduce Multitasking
Most “multitasking” is actually rapid task switching.
And task switching taxes working memory, executive function, and attention.
If those systems are already stressed by poor sleep, anxiety, or hormonal changes, constantly switching tasks can make cognitive symptoms feel substantially worse.
When possible, do cognitively demanding work one task at a time.
7. Look at Alcohol
Alcohol can affect:
- sleep quality
- concentration
- memory
- mood
- hot flashes
Even when alcohol helps someone fall asleep, it can disrupt later stages of sleep.
If brain fog and poor sleep are occurring together, alcohol intake deserves consideration.
8. Be Skeptical of “Brain Fog” Supplements
There is an enormous market for products claiming to restore memory, increase focus, balance estrogen, protect against Alzheimer’s disease, or eliminate menopause brain fog.
Be careful.
A supplement marketed for “cognitive support” is not automatically proven to improve cognition.
Before buying one, ask:
- Was the final product actually studied?
- Was it tested in women going through perimenopause?
- Was the trial randomized and controlled?
- Was the improvement clinically meaningful?
- Could it interact with medications?
Marketing language is not clinical evidence.
Do You Need a Brain Scan?
Usually not for typical perimenopausal brain fog alone.
Evaluation generally begins with:
- symptom history
- progression
- impact on functioning
- menstrual and menopause history
- sleep
- mood
- medications
- alcohol
- medical history
- family history
- neurologic symptoms
Depending on those findings, clinicians may then consider cognitive testing, laboratory testing, neurologic evaluation, or imaging.
A routine brain MRI is not necessary simply because a woman occasionally struggles to retrieve a word during perimenopause.
What About Alzheimer’s Blood Tests?
Blood-based Alzheimer’s biomarkers are advancing rapidly.
They are increasingly useful in appropriate specialty settings when Alzheimer’s disease is genuinely suspected.
But they are not routine screening tests for every healthy 47-year-old experiencing word-finding difficulty and poor sleep.
Testing needs clinical context.
More sensitive testing is not automatically better if the question being asked is the wrong one.
Could Brain Fog Be an Early Sign of Perimenopause?
It can occur during the menopause transition.
But brain fog alone cannot diagnose perimenopause.
For most otherwise healthy women age 45 and older, menopause staging relies primarily on:
- age
- menstrual-cycle changes
- symptoms
- clinical context
Routine hormone testing is generally not necessary.
A single estrogen or FSH level can also be misleading because hormone concentrations fluctuate considerably during perimenopause.
So if you are 47 and simultaneously experiencing changing periods, night sweats, poor sleep, and new concentration problems, those symptoms may reasonably fit together.
But severe, isolated, or progressive cognitive symptoms still deserve a broader evaluation.
Why Brain Fog Is So Easy to Dismiss
This symptom creates an unusual problem.
A woman may appear completely normal during a 20-minute appointment.
She may score normally on brief cognitive testing.
She may still be highly successful at work.
Yet she knows her cognitive workload has become much harder.
The large 2026 community cohort helps explain this disconnect.
Perimenopausal women were significantly more likely to report cognitive symptoms, while objective global cognitive performance differed only minimally across reproductive stages.
The appropriate response to that finding is not: “Then brain fog isn’t real.”
It is: “Our current tests may measure something different from the daily cognitive burden women are describing.”
That is a much more useful starting point.
The Good News: Brain Fog Is Usually Not Progressive Dementia
This distinction deserves emphasis.
Menopause-associated cognitive symptoms tend to be subtle and variable.
They often fluctuate with:
- sleep
- stress
- mood
- vasomotor symptoms
- cognitive load
Progressive neurodegenerative disease behaves differently.
Someone who occasionally cannot retrieve a word after sleeping four hours is experiencing something very different from someone who progressively loses the ability to manage finances, navigate familiar places, understand ordinary conversations, complete familiar tasks, or function independently.
That does not mean brain fog should be dismissed.
It means the pattern and progression matter enormously.
So, Is Your Brain Fog From Perimenopause?
Possibly.
There is now good evidence that women report more cognitive symptoms during the menopause transition, and some research also detects modest changes in specific cognitive domains.
But your brain does not exist separately from the rest of your body or life.
At the same time that hormone levels are changing, cognition can also be affected by:
- sleep
- mood
- stress
- medications
- physical health
- cardiovascular health
- alcohol
- ADHD
- nutritional status
- work demands
- caregiving
- other medical conditions
So the most useful question may not be: “Is estrogen causing this?”
Instead ask:
- When did this begin?
- What else changed around the same time?
- How am I sleeping?
- Is it affecting my ability to function?
- Is it progressively worsening?
- What medications or substances could be contributing?
- Is there anything else medically that needs to be evaluated?
That is a much more useful clinical approach.
The Bottom Line
Brain fog is a common experience during the menopause transition.
The evidence is also becoming more nuanced.
A 2026 meta-analysis of 26 studies involving 9,428 participants found poorer overall cognition among perimenopausal compared with premenopausal women.
But a separate 2026 community study of 14,234 women found that perimenopausal women were substantially more likely to report cognitive symptoms while objective global cognitive performance differed only minimally across menopause stages.
Those findings are not contradictory.
They illustrate how complex cognition is.
Subjective brain fog can be real and disruptive without representing progressive brain disease.
Hormonal changes may contribute, but sleep disruption, vasomotor symptoms, anxiety, depression, ADHD, medications, alcohol, thyroid disease, nutritional deficiencies, sleep disorders, and other conditions can overlap.
Hormone therapy adds another layer of nuance.
Randomized-trial evidence does not show a consistent overall cognitive benefit from MHT. Some subgroup analyses suggest that estrogen started near menopause may have modest effects on specific domains such as verbal memory, while treatment initiated later in life does not show the same pattern.
And hormone therapy should not be prescribed solely to prevent dementia. NICE explicitly recommends against using either combined or estrogen-only HRT for that purpose.
Risk also appears to depend on context.
WHIMS found increased dementia risk when hormone therapy was initiated in women age 65 and older, particularly with combined conjugated estrogen and medroxyprogesterone acetate. Observational data suggest that longer-term estrogen-progestogen therapy may carry a small Alzheimer’s signal that is not seen in the same way with estrogen-only therapy.
That makes broad statements like “estrogen prevents dementia” or “HRT causes dementia” scientifically misleading.
The more useful message is simpler:
Cognitive symptoms can be part of perimenopause. They are usually not the same thing as dementia. And they still deserve to be taken seriously.
The goal is not to blame every forgotten word on estrogen.
It is to understand the whole picture, treat the factors we can treat, and recognize when the pattern warrants a closer look.
This article is for educational purposes only and does not replace individualized medical evaluation, diagnosis, or treatment.
References
- Bangle A, Williams D, Walters J, Nguyen L. Cognitive functioning in perimenopause: An updated systematic review and meta-analysis. Psychology and Aging. 2026;41(3):303-318. doi:10.1037/pag0000946.
- Naysmith LF, Ward H, Elliott P, et al. Cognition and the menopause transition: cross-sectional evidence from a large community cohort. npj Women's Health. 2026;4:14. doi:10.1038/s44294-026-00132-z.
- Zhou K, Cohn M, Novik R, Batur P, Just C. Menopause and Brain Health: Neurobiological Changes, Cognitive Implications, and the Role of Estrogen. Obstetrics and Gynecology Clinics of North America. 2026;53(3):449-461. doi:10.1016/j.ogc.2026.04.001.
- Greendale GA, Karlamangla AS, Maki PM. The menopause transition and cognition. JAMA. 2020;323(15):1495-1496.
- Metcalf CA, Duffy KA, Page CE, Novick AM. Cognitive problems in perimenopause: a review of recent evidence. Current Psychiatry Reports. 2023.
- Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651-2662. doi:10.1001/jama.289.20.2651.
- Vinogradova Y, Dening T, Hippisley-Cox J, Taylor L, Moore M, Coupland C. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. BMJ. 2021;374:n2182. doi:10.1136/bmj.n2182.
- Nerattini M, Jett S, Andy C, et al. Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia. Frontiers in Aging Neuroscience. 2023.
- Mosconi L, Nerattini M, Williams S, Fink M. New horizons in menopause, menopausal hormone therapy, and Alzheimer's disease: current insights and future directions. Journal of Clinical Endocrinology & Metabolism. 2025.
- The National Institute for Health and Care Excellence (NICE). Menopause: identification and management. NG23. Updated guidance. Recommends against offering combined or estrogen-only HRT for dementia prevention.
- National Institute on Aging. Memory, Forgetfulness, and Aging: What's Normal and What's Not?
- Alzheimer's Association. 10 Early Signs and Symptoms of Alzheimer's.
- Bäckström T, Das R, Bixo M. Positive GABA receptor modulating steroids and their antagonists: implications for clinical treatments. Journal of Neuroendocrinology. 2022.
- Structural MRI systematic review of menopausal hormone therapy and brain morphology. 2026. PMID: 41990931.
- Systematic review and meta-analysis of randomized controlled trials examining menopausal hormone therapy and cognition. 2024. PMID: 38501109.
- Evidence and guidelines reviewed through September 2026.
Related care
If this is what you're working through, read more about Menopause & Perimenopause Hormone Therapy.
Ready for the conversation?
Have a real visit with Mallory.
Telehealth visits with one clinician, continuity between visits, and no rotating staff.

